A study conducted by McMahon et al. [29] demonstrated that high leptin levels increased risk of subclinical atherosclerosis in systemic lupus erythematosus, and this was accompanied with elevated levels of inflammatory biomarkers such as Lp(a) and oxPL/apoB100. Here, LEP is linked to atherosclerosis.